Abstract
Purpose
The different mechanisms that trigger the autoimmune attack to the thyroid between Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) are still unclear. The aim of this study was to recognize thyroid antigens specific CD8+ T-cell epitopes and explore the relationship between these epitopes and thyroid autoantibodies, duration and classification in these two diseases.
Methods
Free thiiodothyronine, free tetraiodothyronine, thyroid-stimulating hormone, TgAb, and TPOAb were all measured by immunochemiluminometric assays, while TRAb was tested by radioimmunoassay. HLA class I peptide affinity algorithms were applied to predict candidate thyroid autoantigen peptides that blind to HLA-A*0201. The ELISpot assay was used to detect Tg-, TPO-, and TSHR-specific CD8+ T cells.
Results
We demonstrated that TG-6 was a novel HLA-A*0201-restricted CTL epitope in GD. TG-6, TG-7, TG-10, TG-11, and TPO-6 were immunodominant in GD patients compared with HT patients (TG-6: 38.5 vs. 8%, P = 0.034; TG-7, TG-10, TG-11, and TPO-6: 23.1 vs. 0%, P = 0.034). The immunodominance of TG-6 in GD patients was more evident than healthy controls (HC) (TG-6: 35.8 vs. 0%, P = 0.011), but there was no statistically significant difference between HT patients and HC. Subgroup analyses revealed the T-cell responsiveness to TG-6 was stronger in TgAb-negative HT patients (0 vs. 40%, P = 0.033). However, there was no correlation showed for TPOAb, TRAb, medication and duration in both HT and GD patients.
Conclusions
We report for the first time that both diseases, HT and GD, recognize different antigen-specific CD8-positive T cells. Tg maybe the dominant thyroid autoantigen contributing to breaking tolerance in GD. It could improve our knowledge of autoimmune thyroid diseases pathogenesis as well as offer new therapeutical tools in terms of peptide vaccine therapy.
Similar content being viewed by others
References
A. Antonelli, S.M. Ferrari, A. Corrado, A. Di Domenicantonio, P. Fallahi, Autoimmune thyroid disorders. Autoimmun. Rev. 14(2), 174–180 (2015). https://doi.org/10.1016/j.autrev.2014.10.016
H.B. Burch, D.S. Cooper, Management of Graves disease: a review. JAMA 314(23), 2544–2554 (2015). https://doi.org/10.1001/jama.2015.16535
M. Rydzewska, M. Jaromin, I.E. Pasierowska, K. Stozek, A. Bossowski, Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res. 11, 2 (2018). https://doi.org/10.1186/s13044-018-0046-9
G.P. Leese, R.V. Flynn, R.T. Jung, T.M. Macdonald, M.J. Murphy, A.D. Morris, Increasing prevalence and incidence of thyroid disease in Tayside, Scotland: the Thyroid Epidemiology Audit and Research Study (TEARS). Clin. Endocrinol. 68(2), 311–316 (2008). https://doi.org/10.1111/j.1365-2265.2007.03051.x
S. De Leo, S.Y. Lee, L.E. Braverman, Hyperthyroidism. Lancet 388(10047), 906–918 (2016). https://doi.org/10.1016/S0140-6736(16)00278-6
J.A. Franklyn, K. Boelaert, Thyrotoxicosis. Lancet 379(9821), 1155–1166 (2012). https://doi.org/10.1016/S0140-6736(11)60782-4
S.M. McLachlan, B. Rapoport, Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr. Rev. 35(1), 59–105 (2014). https://doi.org/10.1210/er.2013-1055
A.M. Ramos-Levi, M. Marazuela, Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol. Nutr. 63(8), 421–429 (2016). https://doi.org/10.1016/j.endonu.2016.04.003
H. Mikos, M. Mikos, M. Obara-Moszynska, M. Niedziela, The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol. Pol. 65(2), 150–155 (2014). https://doi.org/10.5603/EP.2014.0021
T.J. Smith, L. Hegedus, Graves’ Disease. N. Engl. J. Med 375(16), 1552–1565 (2016). https://doi.org/10.1056/NEJMra1510030
L. Lamki, V.V. Row, R. Volpe, Cell-mediated immunity in Graves’ disease and in Hashimoto’s \thyroiditis as shown by the demonstration of migration inhibition factor (MIF). J. Clin. Endocrinol. Metab. 36(2), 358–364 (1973). https://doi.org/10.1210/jcem-36-2-358
L.J. Guan, X. Wang, S. Meng, L.F. Shi, W.J. Jiang, L. Xiao, X.H. Shi, J. Xu, J.A. Zhang, Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease. Cytokine 72(2), 160–165 (2015). https://doi.org/10.1016/j.cyto.2014.11.005
F. Menconi, A. Huber, R. Osman, E. Concepcion, E.M. Jacobson, M. Stefan, C.S. David, Y. Tomer, Tg.2098 is a major human thyroglobulin T-cell epitope. J. Autoimmun. 35(1), 45–51 (2010). https://doi.org/10.1016/j.jaut.2010.01.004
C.W. Li, F. Menconi, R. Osman, M. Mezei, E.M. Jacobson, E. Concepcion, C.S. David, D.B. Kastrinsky, M. Ohlmeyer, Y. Tomer, Identifying a small molecule blocking antigen presentation in autoimmune thyroiditis. J. Biol. Chem. 291(8), 4079–4090 (2016). https://doi.org/10.1074/jbc.M115.694687
Q. Deng, Y. Luo, C. Chang, H. Wu, Y. Ding, R. Xiao, The emerging epigenetic role of CD8+T cells in autoimmune diseases: a systematic review. Front Immunol. 10, 856 (2019). https://doi.org/10.3389/fimmu.2019.00856
M. Limbach, M. Saare, L. Tserel, K. Kisand, T. Eglit, S. Sauer, T. Axelsson, A.C. Syvanen, A. Metspalu, L. Milani, P. Peterson, Epigenetic profiling in CD4+ and CD8+ T cells from Graves’ disease patients reveals changes in genes associated with T cell receptor signaling. J. Autoimmun. 67, 46–56 (2016). https://doi.org/10.1016/j.jaut.2015.09.006
Z. Sun, W. Zhong, X. Lu, B. Shi, Y. Zhu, L. Chen, G. Zhang, X. Zhang, Association of Graves’ disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells. J. Clin. Immunol. 28(5), 464–472 (2008). https://doi.org/10.1007/s10875-008-9213-4
M. Ehlers, A. Thiel, C. Bernecker, D. Porwol, C. Papewalis, H.S. Willenberg, S. Schinner, H. Hautzel, W.A. Scherbaum, M. Schott, Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 97(4), 1347–1354 (2012). https://doi.org/10.1210/jc.2011-2178
S. Allelein, A. Kuebart, M. Haase, T. Dringenberg, C. Schmid, M. Schott, M. Ehlers, Measurement of TSH receptor epitope-specific T cells in Graves’ disease. Horm. Metab. Res. 48(12), 862–864 (2016). https://doi.org/10.1055/s-0042-120846
S. Cote-Bigras, A. Dionne, P. Asselin-Mullen, C. Leblicq, D. Rottembourg, Interferon-gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in Graves’ disease. Clin. Endocrinol. 80(2), 296–300 (2014). https://doi.org/10.1111/cen.12257
K. Parker, M. Bednarek, J. Coligan, Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152(1), 163–175 (1994)
C. Lundegaard, K. Lamberth, M. Harndahl, S. Buus, O. Lund, M. Nielsen, NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res. 36(Web Server issue), W509–W512 (2008). https://doi.org/10.1093/nar/gkn202
X. Xu, Y. Gu, L. Bian, Y. Shi, Y. Cai, Y. Chen, H. Chen, L. Qian, X. Wu, K. Xu, R. Mallone, H.W. Davidson, L. Yu, J. She, M. Zhang, T. Yang, Characterization of immune response to novel HLA-A2-restricted epitopes from zinc transporter 8 in type 1 diabetes. Vaccine 34(6), 854–862 (2016). https://doi.org/10.1016/j.vaccine.2015.10.108
R. Mallone, E. Martinuzzi, P. Blancou, G. Novelli, G. Afonso, M. Dolz, G. Bruno, L. Chaillous, L. Chatenoud, J.M. Bach, P. van Endert, CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes. Diabetes 56(3), 613–621 (2007). https://doi.org/10.2337/db06-1419
J.M. Ellis, V. Henson, R. Slack, J. Ng, R.J. Hartzman, C. Katovich Hurley, Frequencies of HLA-A2 alleles in five U.S. population groups. Predominance Of A*02011 and identification of HLA-A*0231. Hum. Immunol. 61(3), 334–340 (2000). https://doi.org/10.1016/s0198-8859(99)00155-x
A. Di Cerbo, R. Di Paola, C. Menzaghi, V. De Filippis, K. Tahara, D. Corda, L.D. Kohn, Graves’ immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor. J. Clin. Endocrinol. Metab. 84(9), 3283–3292 (1999). https://doi.org/10.1210/jcem.84.9.5967
C. Evans, N.G. Morgenthaler, S. Lee, D.H. Llewellyn, R. Clifton-Bligh, R. John, J.H. Lazarus, V.K. Chatterjee, M. Ludgate, Development of a luminescent bioassay for thyroid stimulating antibodies. J. Clin. Endocrinol. Metab. 84(1), 374–377 (1999). https://doi.org/10.1210/jcem.84.1.5532
H.J. Lee, C.W. Li, S.S. Hammerstad, M. Stefan, Y. Tomer, Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J. Autoimmun. 64, 82–90 (2015). https://doi.org/10.1016/j.jaut.2015.07.009
C.W. Li, R. Osman, F. Menconi, E.S. Concepcion, Y. Tomer, Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes. J. Autoimmun. 76, 1–9 (2017). https://doi.org/10.1016/j.jaut.2016.09.007
M. Soliman, E. Kaplan, A. Abdel-Latif, N. Scherberg, L.J. DeGroot, Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients’ T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases? J. Clin. Endocrinol. Metab. 80(8), 2312–2321 (1995). https://doi.org/10.1210/jcem.80.8.7543112
Y. Kawakami, M.E. Fisfalen, L.J. DeGroot, Proliferative responses of peripheral blood mononuclear cells from patients with autoimmune thyroid diseases to synthetic peptide epitopes of human thyroid peroxidase. Autoimmunity 13(1), 17–26 (1992). https://doi.org/10.3109/08916939209014631
M.E. Fisfalen, M. Soliman, Y. Okamoto, K. Soltani, L.J. DeGroot, Proliferative responses of T-cells to thyroid antigens and synthetic thyroid peroxidase peptides in autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 80(5), 1597–1604 (1995). https://doi.org/10.1210/jcem.80.5.7745006
C.M. Dayan, M. Londei, A.E. Corcoran, B. Grubeck-Loebenstein, R.F. James, B. Rapoport, M. Feldmann, Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc. Natl. Acad. Sci. USA 88(16), 7415–7419 (1991). https://doi.org/10.1073/pnas.88.16.7415
S. Quaratino, M. Feldmann, C.M. Dayan, O. Acuto, M. Londei, Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic self-epitope. J. Exp. Med 183(2), 349–358 (1996). https://doi.org/10.1084/jem.183.2.349
E.A. James, M. Pietropaolo, M.J. Mamula, Immune recognition of beta-Cells: neoepitopes as key players in the loss of tolerance. Diabetes 67(6), 1035–1042 (2018). https://doi.org/10.2337/dbi17-0030
Z. Zhao, J. Ren, C. Dai, C.C. Kannapell, H. Wang, F. Gaskin, S.M. Fu, Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification. Ann. Rheum. Dis. 78(3), 380–390 (2019). https://doi.org/10.1136/annrheumdis-2018-214125
Y. Tomer, Y. Ban, E. Concepcion, G. Barbesino, R. Villanueva, D.A. Greenberg, T.F. Davies, Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet. 73(4), 736–747 (2003). https://doi.org/10.1086/378588
W. Ke, T. Sun, Y. Zhang, L. He, Q. Wu, J. Liu, B. Zha, 25-Hydroxyvitamin D serum level in Hashimoto’s thyroiditis, but not Graves’ disease is relatively deficient. Endocr. J. 64(6), 581–587 (2017). https://doi.org/10.1507/endocrj.EJ16-0547
S.A. Morshed, R. Latif, T.F. Davies, Delineating the autoimmune mechanisms in Graves’ disease. Immunol. Res. 54(1–3), 191–203 (2012). https://doi.org/10.1007/s12026-012-8312-8
B. Rapoport, S.M. McLachlan, Graves’ hyperthyroidism is antibody-mediated but is predominantly a Th1-type cytokine disease. J. Clin. Endocrinol. Metab. 99(11), 4060–4061 (2014). https://doi.org/10.1210/jc.2014-3011
M.A. Fernandez-Vina, M. Falco, Y. Sun, P. Stastny, DNA typing for HLA class I alleles: I. Subsets of HLA-A2 and of -A28. Hum. Immunol. 33(3), 163–173 (1992). https://doi.org/10.1016/0198-8859(92)90068-x
H. Park, Y.J. Lee, E.Y. Song, M.H. Park, HLA-A, HLA-B and HLA-DRB1 allele and haplotype frequencies of 10 918 Koreans from bone marrow donor registry in Korea. Int J. Immunogenet. 43(5), 287–296 (2016). https://doi.org/10.1111/iji.12288
Y. Li, H.J. Bao, X. Qiu, Q. Yuan, X. Xu, C. Di, W. Zhang, J. Xu, Z.X. Chen, A study on allele frequencies and mismatching proportion of HLA-A,B,Cw,DRB1 and DQB1 on high-resolution donor-recipient typing in Chinese Han population. Chin. J. Med. Genet. 28(1), 7 (2011)
M. Pan, Z.X. Pan, Q. Fan, S. Wang, X. Wang, C. Shen J, Study on the analysis of high-resolution HLA-A, B and DRB1 alleles from 3238 hematopoietic stem cell donors in Jiangsu Han Chinese. Zhonghua Xue Ye Xue Za Zhi 33(2), 4 (2012)
L. Muixi, M. Carrascal, I. Alvarez, X. Daura, M. Marti, M.P. Armengol, C. Pinilla, J. Abian, R. Pujol-Borrell, D. Jaraquemada, Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands. J. Immunol. 181(1), 795–807 (2008). https://doi.org/10.4049/jimmunol.181.1.795
K. Sakai, S. Shirasawa, N. Ishikawa, K. Ito, H. Tamai, K. Kuma, T. Akamizu, M. Tanimura, K. Furugaki, K. Yamamoto, T. Sasazuki, Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto’s thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum. Mol. Genet 10(13), 1379–1386 (2001). https://doi.org/10.1093/hmg/10.13.1379
Y. Tomer, D.A. Greenberg, E. Concepcion, Y. Ban, T.F. Davies, Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 87(1), 404–407 (2002). https://doi.org/10.1210/jcem.87.1.8291
S. Ueda, D. Oryoji, K. Yamamoto, J.Y. Noh, K. Okamura, M. Noda, K. Kashiwase, Y. Kosuga, K. Sekiya, K. Inoue, H. Yamada, A. Oyamada, Y. Nishimura, Y. Yoshikai, K. Ito, T. Sasazuki, Identification of independent susceptible and protective HLA alleles in Japanese autoimmune thyroid disease and their epistasis. J. Clin. Endocrinol. Metab. 99(2), E379–E383 (2014). https://doi.org/10.1210/jc.2013-2841
Acknowledgements
This study was supported by grants from the National Natural Science Foundation of China (numbers 81530026, 81970707, and 81830023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Cai, Y., Xu, X., Zhang, Z. et al. Identification of novel HLA-A0201-restricted T-cell epitopes against thyroid antigens in autoimmune thyroid diseases. Endocrine 69, 562–570 (2020). https://doi.org/10.1007/s12020-020-02264-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-020-02264-x